Related Experiment Video

Updated: Apr 25, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27

Lijia Zhu1, Christine Y Chiao1, Katelyn G Enzer1

  • 1Cancer Center and Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.

Molecular Cancer Research : MCR
|August 22, 2014
PubMed
Abstract

Insights

SIRT1 reduces p27 protein levels, impacting cancer progression. Inhibiting SIRT1 reactivates p27, inducing senescence and suppressing non-small cell lung cancer growth in vivo.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • p27(Kip1) (CDKN1B) loss correlates with poor prognosis in many cancers.
  • Understanding p27(Kip1) regulation is crucial for cancer therapy.
  • SIRT1, a histone deacetylase, is implicated in cellular processes.

Purpose of the Study:

  • To investigate SIRT1's role in regulating p27(Kip1) expression.
  • To determine the therapeutic potential of SIRT1 inhibition in non-small cell lung cancer (NSCLC).

Main Methods:

  • Investigated the mechanism of SIRT1-mediated p27(Kip1) regulation.
  • Utilized cell culture models of NSCLC.
  • Employed NSCLC xenograft mouse models to assess in vivo efficacy.

Main Results:

  • SIRT1 was identified as a key regulator of p27(Kip1) expression.
  • SIRT1 reduces p27(Kip1) protein stability via the ubiquitin-proteasome pathway.
  • SIRT1 silencing suppressed NSCLC proliferation and induced p27(Kip1)-dependent senescence.
  • SIRT1 inhibition significantly reduced tumor formation and growth in vivo.

Conclusions:

  • SIRT1 is a critical regulator of p27 protein levels.
  • SIRT1 inhibition represents a viable therapeutic strategy for NSCLC by reactivating p27.

More Related Videos

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

7.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K